About US
Contact us
-
Abbott and AbbVie settle TriCor marketing caseAmerican healthcare company Abbott Laboratories and AbbVie have reached a $25m settlement with US authorities to resolve charges that they paid kickbacks to doctors to encourage them to prescribechole2018/10/30
-
JW Pharmaceutical invests in British anti-cancer drugs developerSouth Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics. This investment gives JW Pharmaceutical a 25% shar2018/10/30
-
Pfizer works to get 'wait-and-see' doctors on board the Ibrance trainMUNICH—Evidence in favor of the relatively new CDK 4/6 class of breast cancer drugs, which stars Pfizer’s Ibrance, continues to pile up—but it hasn’t yet been enough to convince some doctors to give t2018/10/29
-
Opdivo will keep growing, Bristol-Myers says, trying to talk investors off the ledgeIt’s no secret that Bristol-Myers Squibb’s investors are feeling skittish after a pair of negative Opdivo developments last week. And on Thursday’s third-quarter conference call, executives plunged ri2018/10/29
-
UK crackdown yields £2m of counterfeit medicinesThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has seized more than one million doses of fake medicines with a combined worth of nearly £2m. The crackdown on counterfeit medi2018/10/26
-
Trump signs bipartisan opioid bill into law to tackle rising US crisisUS President Donald Trump has signed a bipartisan opioid bill into law called SUPPORT for Patients and Communities Act to combat a growing substance crisis in the country. According to areport by the2018/10/26
-
FDA approves first new influenza treatment in two decadesThe US Food and Drug Administration (FDA) has granted approval of Xofluza (baloxavir marboxil) to Japanese pharmaceutical company Shionogi for the treatment of acute uncomplicated influenza (flu). Sa2018/10/25
-
MPs told public may need to stockpile drugs in no-deal BrexitThe UK pharmaceutical industry bodies have told MPs that patients may need to stockpile their own drugs in case of a no-deal Brexit, which could result in ‘catastrophic consequences’ for drug supply.2018/10/25
-
Merck KGaA opens $72M distribution facility at German headquartersMerck KGaA has opened a new distribution center as it continues to streamline its manufacturing and build up the production site at its headquarters in Darmstadt, Germany. The €63 million ($72.3 mill2018/10/24
-
GlaxoSmithKline expands API production for COPD inhalers as Advair sales witherEven with looming generic competition expected to take a big bite out of sales of its blockbuster Advair, respiratory drugs remain key to GlaxoSmithKline, and itcontinues to plow money into their prod2018/10/24